FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2418680306> ?p ?o ?g. }

• W2418680306 endingPage "20" @default.
• W2418680306 startingPage "15" @default.
• W2418680306 abstract "Toxicity to the bone marrow is a frequent limiting factor in the use of high doses of chemotherapeutic agents. Bone marrow transplantation overcomes the marrow toxicity problem, but it is not protective to other organs. Extensive animal studies have been carried out in the mouse, the rat, rhesus monkeys, and dogs to delineate the dose-limiting toxicity of cyclophosphamide (Cytoxan) (CY) therapy. Studies in the dog have shown 100 mg/kg of CY to be lethal with supportive care alone. Dogs given this dose followed by stored autologous marrow recovered after a period of profound pancytopenia and severe gastrointestinal toxicity. This dose of CY also permitted allogeneic engraftment in the dog. Monkeys given up to 200 mg/kg of CY have uneventful hematopoietic recovery, but doses of 240 mg/kg were generally fatal even when stored autologous marrow was infused. Cardiac toxicity was the limiting factor. CY 180 mg/kg was not lethal and permitted successful allogeneic marrow engraftment. CY is successfully used for conditioning leukemia or aplastic anemia patients for bone marrow transplantation. Patients with severe aplastic anemia are conditioned with CY 50 mg/kg on each of four days followed by allogeneic marrow transplantation. Patients undergoing transplantation before transfusion have a long-term survival rate of about 80%. Patients with genetic disorders of the marrow generally have a normocellular or hypercellular marrow, and the preparative regimen must include destruction of the abnormal marrow as well as immunosuppression sufficient to permit engraftment. Patients with thalassemia are treated with dimethylbusulfan 5 mg/kg or busulfan 14 mg/kg followed by CY 50 mg/kg on each of four days. Approximately 100 thalassemia patients have been treated, with a survival rate of approximately 75%. For patients with leukemia, radiotherapy is generally added to the CY conditioning regimen. In the early Seattle studies, 1,000 rad total body irradiation was combined with CY 60 mg/kg on each of two days. There were many early deaths, but some long-term survivors are alive and well 5 to 13 years later. Current regimens involve fractionated total body irradiation and various post-grafting immunosuppressive regimens designed to prevent graft-v-host disease. Complications and problems of current regimens are discussed, and future goals for marrow transplantation are presented." @default.
• W2418680306 created "2016-06-24" @default.
• W2418680306 creator A5089314070 @default.
• W2418680306 date "1985-12-01" @default.
• W2418680306 modified "2023-09-23" @default.
• W2418680306 title "High-dose therapy and bone marrow transplantation." @default.
• W2418680306 cites W148372795 @default.
• W2418680306 cites W1522048276 @default.
• W2418680306 cites W1533467312 @default.
• W2418680306 cites W1843903027 @default.
• W2418680306 cites W193514409 @default.
• W2418680306 cites W1979123982 @default.
• W2418680306 cites W1980940217 @default.
• W2418680306 cites W1985883917 @default.
• W2418680306 cites W1997662788 @default.
• W2418680306 cites W2014249858 @default.
• W2418680306 cites W2048565864 @default.
• W2418680306 cites W2074934754 @default.
• W2418680306 cites W2130072228 @default.
• W2418680306 cites W2298707981 @default.
• W2418680306 cites W2325242860 @default.
• W2418680306 cites W2327441947 @default.
• W2418680306 cites W2339482838 @default.
• W2418680306 cites W2402227730 @default.
• W2418680306 cites W2412292918 @default.
• W2418680306 cites W2413863391 @default.
• W2418680306 cites W2416628416 @default.
• W2418680306 cites W2417084206 @default.
• W2418680306 cites W2468688977 @default.
• W2418680306 cites W307132063 @default.
• W2418680306 cites W5387557 @default.
• W2418680306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3909418" @default.
• W2418680306 hasPublicationYear "1985" @default.
• W2418680306 type Work @default.
• W2418680306 sameAs 2418680306 @default.
• W2418680306 citedByCount "5" @default.
• W2418680306 crossrefType "journal-article" @default.
• W2418680306 hasAuthorship W2418680306A5089314070 @default.
• W2418680306 hasConcept C126322002 @default.
• W2418680306 hasConcept C141071460 @default.
• W2418680306 hasConcept C2776694085 @default.
• W2418680306 hasConcept C2776755627 @default.
• W2418680306 hasConcept C2778461978 @default.
• W2418680306 hasConcept C2779382419 @default.
• W2418680306 hasConcept C2779968505 @default.
• W2418680306 hasConcept C2780007613 @default.
• W2418680306 hasConcept C2780611847 @default.
• W2418680306 hasConcept C2781440808 @default.
• W2418680306 hasConcept C2911091166 @default.
• W2418680306 hasConcept C29730261 @default.
• W2418680306 hasConcept C71924100 @default.
• W2418680306 hasConceptScore W2418680306C126322002 @default.
• W2418680306 hasConceptScore W2418680306C141071460 @default.
• W2418680306 hasConceptScore W2418680306C2776694085 @default.
• W2418680306 hasConceptScore W2418680306C2776755627 @default.
• W2418680306 hasConceptScore W2418680306C2778461978 @default.
• W2418680306 hasConceptScore W2418680306C2779382419 @default.
• W2418680306 hasConceptScore W2418680306C2779968505 @default.
• W2418680306 hasConceptScore W2418680306C2780007613 @default.
• W2418680306 hasConceptScore W2418680306C2780611847 @default.
• W2418680306 hasConceptScore W2418680306C2781440808 @default.
• W2418680306 hasConceptScore W2418680306C2911091166 @default.
• W2418680306 hasConceptScore W2418680306C29730261 @default.
• W2418680306 hasConceptScore W2418680306C71924100 @default.
• W2418680306 hasIssue "4 Suppl 6" @default.
• W2418680306 hasLocation W24186803061 @default.
• W2418680306 hasOpenAccess W2418680306 @default.
• W2418680306 hasPrimaryLocation W24186803061 @default.
• W2418680306 hasRelatedWork W2030099060 @default.
• W2418680306 hasRelatedWork W2039189707 @default.
• W2418680306 hasRelatedWork W2065195476 @default.
• W2418680306 hasRelatedWork W2326794969 @default.
• W2418680306 hasRelatedWork W2332703162 @default.
• W2418680306 hasRelatedWork W2416978002 @default.
• W2418680306 hasRelatedWork W2418680306 @default.
• W2418680306 hasRelatedWork W2558568798 @default.
• W2418680306 hasRelatedWork W43183315 @default.
• W2418680306 hasRelatedWork W2181783475 @default.
• W2418680306 hasVolume "12" @default.
• W2418680306 isParatext "false" @default.
• W2418680306 isRetracted "false" @default.
• W2418680306 magId "2418680306" @default.
• W2418680306 workType "article" @default.